Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED